Registration number: 13394965

Pharmapipe Limited

Contents

Company Information	1
Balance Sheet	2 to 3
Notes to the Unaudited Financial Statements	2

Pharmapipe Limited

Company Information

Directors

D Fitzgerald D Fitzpatrick

Registered office

1st Floor Suite A3 Sovereign House Stockport Road Cheadle SK8 2EA

Accountants

HGR Accountants Limited 3 Linden Road Cheadle Hulme Cheshire SK8 5NB

Pharmapipe Limited

(Registration number: 13394965)
Balance Sheet as at 31 December 2025

	2025 £	2025 £
Fixed assets	11,010	14,782
Current assets	265,693	181,131
Prepayments and accrued income	4,350	11,633
Creditors: Amounts falling due within one year	(100,790)	(74,754)
Net current assets	169,253	118,010
Total assets less current liabilities	180,263	132,792
Creditors: Amounts falling due after more than one year	(141,358)	-
Accruals and deferred income	(5,000)	(5,000)
	33,905	127,792
Capital and reserves	33,905	127,792

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
1st Floor Suite A3
Sovereign House
Stockport Road
Cheadle
SK8 2EA

These financial statements were authorised for issue by the Board on 25 September 2026.

2	Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2 (2025 - 2).

For the financial period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Pharmapipe Limited

(Registration number: 13394965)
Balance Sheet as at 31 December 2025

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 September 2026 and signed on its behalf by:
 

......................................... D Fitzgerald Director